We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Pericardial Drain Removal Safe Following Cardiac Tamponade

By Daniel Beris
Posted on 14 Dec 2016
Print article
After treating cardiac tamponade arising from atrial fibrillation (AF) catheter ablation, pericardial drains do not need to be kept in place for an additional day, according to a new study.

Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a retrospective descriptive analysis study of 43 cases of cardiac tamponade resulting from complication of atrial fibrillation catheter ablation (AFCA) procedures between 2006 and 2015 in order to examine the safety of early removal of pericardial drains. The researcher compared 25 patients in whom the drain was removed early to 18 patients who underwent traditional delayed removal. Cardiac tamponade was diagnosed when pericardial effusion led to hypoperfusion and systolic blood pressure dropped below 80 mm Hg.

In cases that employed early removal strategy, the pericardial space was monitored for reaccumulation for a minimum of 30 minutes, with repeated transthoracic echocardiography. Once it reached dryness, the patient was deemed ready to leave the laboratory and the drain was left to operator discretion for removal. The delayed removal group was monitored for an extra 17 hours once no reaccumulation was confirmed. The main outcomes included need for repeat pericardiocentesis, major adverse outcomes, length of stay, and need for opiate analgesia.

The results showed that not one of the AF patients who had the drains taken out early needed repeat pericardiocentesis before hospital discharge. They also had a moderately shorter length of stay than their peers who had drain removal delayed in case of re-bleeding, and also went back on anticoagulation earlier. In addition, few patients with early removal needed opiate analgesia (8%) compared to the delayed removal group (72%). The study was published on November 15, 2016, in JACC: Clinical Electrophysiology.

“Early removal of pericardial drains after tamponade complicating atrial fibrillation catheter ablation procedures appears to be safe and effective, with re-insertion not required in this cohort,” concluded lead author Michala Pedersen, MD, and colleagues. “The traditional practice of leaving drains in situ for 12 to 24 hours may result in more patient discomfort and longer hospitalization. Additionally, there may be benefits to health economics.”

Cardiac tamponade occurs when fluid in the pericardium accumulates, resulting in compression of the heart. Symptoms typically include shortness of breath, weakness, lightheadedness, and cough. If fluid increases slowly the pericardial sac can expand to contain more than two liters; however, if the increase is rapid, as little as 200 mL can result in tamponade. When tamponade results in symptoms, drainage is necessary, by pericardiocentesis, a pericardial window, or a pericardiectomy. Tamponade due to AFCA is traditionally managed by pericardiocentesis with delayed removal of the drain (typically 12 to 24 hours later) in case of re-bleeding.

Related Links:
John Radcliffe Hospital

Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Needlefree Closed System Transfer Device
ChemoClave

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.